Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Aug. 31, 2020	Aug. 31, 2019
Cash flows from operating activities:
Net loss	$ (2,550)	$ (9,536)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	5,290	6,128
Amortization of debt discount	395	411
Bad debt expense		104
Reduction in the carrying amount of the right of use asset	508	459
Gain on forward contracts	(54)	(213)
Equity in income of equity investees	(2,745)	(2,705)
Distribution of income from equity investees	2,364	2,903
Deferred income tax expense (benefit)	2,969	(1,276)
Non-cash compensation adjustment	(443)	(88)
Stock based compensation expense	686	1,345
Loss on sale of property, plant, and equipment		18
Changes in operating assets and liabilities:
Accounts receivable	(27,932)	4,386
Inventory	(18,714)	(12,791)
Receivables from vendors	(336)	641
Prepaid expenses and other	(3,064)	1,213
Investment securities-trading	443	340
Accounts payable, accrued expenses, accrued sales incentives, and other liabilities	42,400	(3,475)
Income taxes payable	693	(738)
Net cash used in operating activities	(90)	(12,874)
Cash flows used in investing activities:
Purchases of property, plant, and equipment	(1,104)	(1,332)
Purchase of acquired business, less cash received	(11,000)
Proceeds from sale of property, plant, and equipment		26
Net cash used in investing activities	(12,104)	(1,306)
Cash flows provided by (used in) financing activities:
Principal payments on finance lease obligation	(329)	(310)
Repayment of bank obligations	(250)	(3,356)
Borrowings on bank obligations	20,335
Deferred financing costs	(260)
Purchase of treasury stock		(983)
Net cash provided by (used in) financing activities	19,496	(4,649)
Effect of exchange rate changes on cash	1,162	(113)
Net increase (decrease) in cash and cash equivalents	8,464	(18,942)
Cash and cash equivalents at beginning of period	37,425	58,236
Cash and cash equivalents at end of period	$ 45,889	$ 39,294